Intelligent Bio Solutions rise after clearing security tests ahead of FDA filing

Intelligent Bio Solutions

17/04/2026 13:37

** Shares of medical device maker Intelligent Bio Solutions  INBS.O rise about 12% to $3.03 premarket

** Co says it completed independent security testing for its fingerprint-based drug-screening system ahead of U.S. FDA submission

** System checks sweat from a fingerprint to screen for drugs such as opioids, cocaine, methamphetamine and cannabis, offering rapid results

** Co says external penetration testing found no major security weaknesses

** Added safeguards include encrypted ID tags and upgraded device software to protect user data

** Clearance can help expand use of the system in the U.S. workplace drug testing market, which co says is worth billions

** As of last close, stock down ~72% YTD

 (Reporting by Sahil Pandey in Bengaluru)

 ((Sahil.Pandey@thomsonreuters.com))